OpenDNA Signed Agreement With Eve Investment’s Meluka Honey To Sell Honey Via RooLife

OpenDNA Signed Agreement With Eve Investment’s Meluka Honey To Sell Honey Via RooLife

OpenDNA Limited (ASX: OPN) is and AI/Machine Learning development and as e-commerce marketing Australian firm. On 12 March, the company announced that it has entered into the binding agreement with EVE Investment’s (ASX: EVE) Meluka Honey, to lead its entry into Chinese market, and to drive online sales for its honey products in China through OPN’s RooLife platform.

As per the agreement, OPN is expected to generate income by provide market entry assistance, digital marketing offerings and the commissions on the sales via RooLife platform of the company. 

The term for distribution of products of Meluka Honey is for the beginning 12 months, with an option to further extend the distribution for another 12 months. The collaboration complements OPN’s business strategy to sell/market authentic Australian products to specifically cater to growing Chinese consumer demand for natural products. Meluka Honey is anticipated to have a high demand in China. The statistics state that since 2013, a consistent growth was observed in the consumption of natural honey in China, which has increased by 112.5%.

RooLife e-Commerce platform involves refining the products offered to clients based on their customer needs, with the integration of the Artificial Intelligence System of OpenDNA, At the same time, it would be able to collect information about the customers preferences and buying habits of the customers.

Mr Bryan Carr, who is the CEO of OpenDNA stated that it is a win-win situation for both the companies. He further highlighted that High-quality Australian honey is highly demanded in China. With the unique properties of Meluka Honey, OPN believes that it would be able to get differentiated in the market. He also stated that it would be a source of attraction to consumers, since it not only tasted good, but it also had anti-oxidant and sustained anti-microbial qualities.

This agreement between OpenDNA and EVE Investment’s Meluka Honey is also a significant step, towards establishing the Meluka Honey brand in the Asian markets. The two key driving factors of the product in the Chinese market, are the strong belief of the end users in the natural medicinal properties of honey, and the trust in terms of quality and safety of the Australian made products.

The projection for the year 2024, by various Global Industry Analysts, Inc. USA, stated that honey consumption would exceed 2.8 tonnes around the world.

On 27 February, OpenDNA had signed a binding agreement with Better Nature Australia (producer/seller of naturally sources products) to drive its market entry and online sales/marketing in China.

On 25 February 2019, the company secured a supply channel agreement with NNM Services for marketing and distributing the products from NNM suppliers into China.

In the last six months, the stock has generated a return of 42.86%. By the end of the trading period on the 12 March 2019, the shares of OPN closed at A$0.050, which was, down by 3.846%. Today (13 March, 12:50 PM AEST), the stock is trading flat at A$0.050. The company has a market capitalization of A$10.34 million with approximately 206.87 million outstanding shares.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Top 25 Dividend Stocks report for April

People prefer a dividend stock in their portfolio as it possesses the feature of compounding. Compounding means that the earning which is generated through these dividend stock will get reinvested and will eventually create earnings from earning. More precisely, the dividend generated from these dividend stock will get reinvested to buy another set of a share of the dividend stock which results in giving a higher dividend.

Click here to download your top 25 dividend stocks report!

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here